pRED

Roche blueprints a $1.8B R&D complex for pRED
Fierce Biotech
Wed, 10/22/14 - 09:56 am
Roche
R&D
pRED
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Fri, 01/17/14 - 05:54 pm
JPMHC 2014
Algeta
Macrogenics
Xencor
Acetylon
Enanta Pharmaceuticals
Clinigen
Iroko Pharmaceuticals
Protalix BioTherapeutics
Ambrx
Roche
Sialix
Verastem
pRED
Cubist Pharmaceuticals
Celgene
Otonomy
Lumena Pharmaceuticals
Roche's dealmakers at pRED will continue their global shopping spree in 2014
Fierce Biotech
Thu, 01/16/14 - 09:23 am
Roche
pRED
R&D
Completing a U-turn on RNA, Roche's resurgent pRED strikes deal with Santaris
Fierce Biotech
Sat, 01/11/14 - 08:06 am
RNA
Roche
Santaris
pRED
R&D